Literature DB >> 10751549

Capsaicin-stimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms.

J Purkiss1, M Welch, S Doward, K Foster.   

Abstract

Capsaicin, the pungent component of "hot" chili peppers, selectively activates a distinct population of primary sensory neurons responsive to noxious stimuli. Many of these fibres express neuropeptides including the tachykinin, substance P. Using cultured dorsal root ganglion neurons, we found that capsaicin (10 microM) stimulated a 2-fold increase in release of substance P in the absence of extracellular Ca(2+). Elevated potassium (75 mM) was unable to induce release under these conditions. The introduction of Ca(2+) enhanced capsaicin-induced release and brought about a robust response to potassium. Preincubation of cells with botulinum neurotoxin A (100 nM) completely blocked potassium-induced release but the capsaicin response, in the absence of Ca(2+), was unaffected. However, toxin treatment dramatically reduced capsaicin-stimulated release in the presence of Ca(2+). It is concluded that capsaicin induces release of substance P from dorsal root ganglion neurons via two mechanisms, one requiring extracellular Ca(2+) and the intact synaptosomal-associated protein 25 kDa (SNAP-25), and the other independent of extracellular Ca(2+) and not involving SNAP-25.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10751549     DOI: 10.1016/s0006-2952(00)00260-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  52 in total

1.  [Pharmacology of botulinum toxin drugs].

Authors:  D Dressler
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

Review 2.  Evidence-based knee injections for the management of arthritis.

Authors:  Olivia T Cheng; Dmitri Souzdalnitski; Bruce Vrooman; Jianguo Cheng
Journal:  Pain Med       Date:  2012-05-23       Impact factor: 3.750

Review 3.  Botulinum neurotoxin - from laboratory to bedside.

Authors:  K A Foster; H Bigalke; K R Aoki
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 4.  [Pharmacological aspects of therapeutic botulinum toxin preparations].

Authors:  D Dressler
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

Review 5.  Botulinum A toxin for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms.

Authors:  Catherine A Thomas; Yao-Chi Chuang; Antonella Giannantoni; Michael B Chancellor
Journal:  Curr Urol Rep       Date:  2006-07       Impact factor: 3.092

6.  Local therapies in migraine.

Authors:  Marco Aguggia
Journal:  Neurol Sci       Date:  2009-05       Impact factor: 3.307

Review 7.  Treating headaches with botulinum toxin.

Authors:  Marco Aguggia
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

8.  Two mechanisms involved in trigeminal CGRP release: implications for migraine treatment.

Authors:  Paul L Durham; Caleb G Masterson
Journal:  Headache       Date:  2012-10-23       Impact factor: 5.887

9.  The role of substance P in acupuncture signal transduction and effects.

Authors:  Yu Fan; Do-Hee Kim; Young Seob Gwak; Danbi Ahn; Yeonhee Ryu; Suchan Chang; Bong Hyo Lee; Kyle B Bills; Scott C Steffensen; Chae Ha Yang; Hee Young Kim
Journal:  Brain Behav Immun       Date:  2020-09-18       Impact factor: 7.217

Review 10.  Botulinum toxin therapy for myofascial pain disorders.

Authors:  Amy M Lang
Journal:  Curr Pain Headache Rep       Date:  2002-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.